Cargando…
Butylphthalide Combined With Conventional Treatment Attenuates MMP-9 Levels and Increases VEGF Levels in Patients With Stroke: A Prospective Cohort Study
Background and Purpose: Butylphtalide increases the vascular endothelial growth factor (VEGF) and decreases matrix metalloproteinase (MMP)-9 in animal models of stroke and might be of use in the management of stroke. To explore whether butylphthalide combined with conventional treatment can change t...
Autores principales: | Xiong, Yingqiong, Liu, Juanjuan, Xu, Yang, Xie, Shu, Zhou, Xinhua, Cheng, Shaomin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720749/ https://www.ncbi.nlm.nih.gov/pubmed/34987460 http://dx.doi.org/10.3389/fneur.2021.686199 |
Ejemplares similares
-
MMP-9-Related microRNAs as Prognostic Markers for Hemorrhagic Transformation in Cardioembolic Stroke Patients
por: Zheng, Lukai, et al.
Publicado: (2019) -
MMP-9 as a Biomarker for Predicting Hemorrhagic Strokes in Moyamoya Disease
por: Lu, Junlin, et al.
Publicado: (2021) -
Immunoexpression of MMP-8 and MMP-9 in chronic subdural hematoma
por: Su, Gao-Jian, et al.
Publicado: (2022) -
A potential relationship between MMP-9 rs2250889 and ischemic stroke susceptibility
por: Ge, Hanming, et al.
Publicado: (2023) -
Efficacy and Safety of Adherence to dl-3-n-Butylphthalide Treatment in Patients With Non-disabling Minor Stroke and TIA—Analysis From a Nationwide, Multicenter Registry
por: Tan, Zefeng, et al.
Publicado: (2021)